CAY10505 in (ML246) Treatment of diet-induced obese mice

Treatment of diet-induced obese mice with SR9009 decreased obesity by reducing fat mass and markedly improved dyslipidaemia and hyperglycaemia

1 mg/kg) partially reversed the decrease of choline acetyltransferase activity in the fronto-parietal cortex induced by basal forebrain-lesion

irreversible inhibitor of the enzyme ornithine decarboxylase

Chemical Name: 2-((4-cyanophenyl)amino)-N-(2-(cyclohexylamino)-2-oxo-1-(o-tolyl)ethyl)-N-(3-fluorophenyl)acetamide

high affinity

CAY10505 in (ML246) Treatment of diet-induced obese miceCAY10505 is a phosphatidylinositol 3 kinase inhibitor , was found to significantly improve acetylcholine induced endothelium dependent relaxation, serum nitrate and (or) nitrite level, glutathione level, and the vascular endothelial lining in hypertensive rats. CAY10505 , may improve hypertension associated vascular endothelial dysfunction. Inhibition of PI3K might be a useful approach in the therapeutics of vascular endothelium dysfunction. Product